Interferon Alpha in Systemic Lupus Erythematosus
Open Access
- 29 June 2010
- journal article
- review article
- Published by Hindawi Limited in Journal of Biomedicine and Biotechnology
- Vol. 2010, 1-8
- https://doi.org/10.1155/2010/948364
Abstract
The pleiotropic cytokine interferon alpha is involved in multiple aspects of lupus etiology and pathogenesis. Interferon alpha is important under normal circumstances for antiviral responses and immune activation. However, heightened levels of serum interferon alpha and expression of interferon response genes are common in lupus patients. Lupus-associated autoantibodies can drive the production of interferon alpha and heightened levels of interferon interfere with immune regulation. Several genes in the pathways leading to interferon production or signaling are associated with risk for lupus. Clinical and cellular manifestations of excess interferon alpha in lupus combined with the genetic risk factors associated with interferon make this cytokine a rare bridge between genetic risk and phenotypic effects. Interferon alpha influences the clinical picture of lupus and may represent a therapeutic target. This paper provides an overview of the cellular, genetic, and clinical aspects of interferon alpha in lupus.Keywords
This publication has 87 references indexed in Scilit:
- Autoreactive B Cell Responses to RNA-Related Antigens Due to TLR7 Gene DuplicationScience, 2006
- Opn: key regulator of pDC interferon productionNature Immunology, 2006
- U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7Blood, 2006
- IκB kinase-α is critical for interferon-α production induced by Toll-like receptors 7 and 9Nature, 2006
- In vitro‐Generated Viral Double‐Stranded RNA in Contrast to Polyinosinic : Polycytidylic Acid Induces Interferon‐α in Human Plasmacytoid Dendritic CellsScandinavian Journal of Immunology, 2006
- Quick Generation of Fully Mature Dendritic Cells From Monocytes With OK432, Low-Dose Prostanoid, and Interferon-?? as Potent Immune EnhancersJournal of Immunotherapy, 2006
- Association of anti-nucleoprotein autoantibodies with upregulation of Type I interferon-inducible gene transcripts and dendritic cell maturation in systemic lupus erythematosusClinical Immunology, 2005
- Type I interferon correlates with serological and clinical manifestations of SLEAnnals Of The Rheumatic Diseases, 2005
- Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosusThe Journal of Experimental Medicine, 2005
- Activation of the interferon‐α pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active diseaseArthritis & Rheumatism, 2005